What is KPV used for in research?

Most KPV data come from mouse colitis models. Dalmasso et al. (2008) found that oral KPV reduced intestinal inflammation and lowered inflammatory cytokines in mice, because PepT1, a small-peptide transporter in the gut lining, carries it into cells. Once inside, it blocked activation of NF-κB, a master switch for cytokines such as TNF-α and IL-6.

Other work covers human keratinocytes in culture and antimicrobial assays against Staphylococcus aureus, where α-MSH peptides including KPV acted against the bacteria without reducing neutrophil function. Its anti-inflammatory effects held up in mice lacking the melanocortin-1 receptor. There’s no human clinical data. Read our research purposes only policy, then shop KPV peptide.